Why don't we have all the evidence on oseltamivir? por Godlee, F, Clarke, M

Surgical mesh and patient safety por Heneghan, C, Godlee, F

Where next for evidence based healthcare? por Heneghan, C, Godlee, F

Why the assisted dying bill should become law in England and Wales por Delamothe, T, Snow, R, Godlee, F

Too much medicine: from evidence to action. por Moynihan, R, Heneghan, C, Godlee, F

Evidence based medicine manifesto for better healthcare. por Heneghan, C, Mahtani, K, Goldacre, B, Godlee, F, Macdonald, H, Jarvies, D

Evidence based medicine manifesto for better healthcare: A response to systematic bias, wastage, error and fraud in research underpinning patient care. por Heneghan, C, Mahtani, K, Goldacre, B, Godlee, F, Macdonald, H, Jarvies, D

Journal policy on research funded by the tobacco industry. por Godlee, F, Malone, R, Timmis, A, Otto, C, Bush, A, Pavord, I, Groves, T

Journal policy on research funded by the tobacco industry. por Godlee, F, Malone, R, Timmis, A, Otto, C, Bush, A, Pavord, I, Groves, T

Journal policy on research funded by the tobacco industry: The BMJ, Thorax, Heart, and BMJ Open join Tobacco Control in no longer considering such research por Godlee, F, Malone, R, Timmis, A, Otto, C, Bush, A, Pavord, I, Groves, T

Journal policy on research funded by the tobacco industry. por Godlee, F, Malone, R, Timmis, A, Otto, C, Bush, A, Pavord, I, Groves, T

Characterisation of trials where marketing purposes have been influential in study design: a descriptive study. por Barbour, V, Burch, D, Godlee, F, Heneghan, C, Lehman, R, Perera, R, Ross, J, Schroter, S

Open letter: European Medicines Agency should remove barriers to access clinical trial data. por Goldacre, B, Godlee, F, Heneghan, C, Tovey, D, Lehman, R, Chalmers, I, Barbour, V, Brown, T